Cell And Gene Therapy Videos
-
How To Boost AAV Titer With Feed Supplementation In Both HEK293 And Sf-9 Platforms
11/25/2024
Explore how optimizing post-transfection or post-infection feeding in HEK293 and Sf-9 cells significantly boosts AAV titers, enhancing production efficiency for gene therapy applications.
-
Plasmid DNA For Cell & Gene Therapy: It All Starts Here
11/25/2024
Explore how tailored manufacturing solutions can enhance program outcomes, leverage cutting-edge technologies for research and discovery, and optimize preclinical applications.
-
Using An Adherent Platform To Scale-Up An Upstream Viral Vector Process
11/20/2024
Gain insight into a helper-dependent adenovirus (HDAd) process that covers everything from bench-scale and optimization to tech transfer.
-
Breaking Through Supply Chain Bottlenecks In CGT
11/12/2024
Industry experts share actionable solutions for tackling raw material variability, temperature-controlled logistics, and post-manufacturing storage, ensuring efficient, scalable operations.
-
Harnessing mRNA Quality Insights: Essential Techniques For Rapid Drug Development
11/11/2024
Chief Scientific Officer and Founder Christian Cobaugh, Ph.D., examines the critical quality attributes of mRNA and LNPs that are pivotal to enhancing drug efficacy and safety.
-
From iPSCs To Functional NK Cell Therapy - A Client Journey
10/30/2024
Discover how iPSC-based allogeneic cell therapies, guided by Cellistic's top experts and powered by Pulse and Echo platforms, are set to transform healthcare.
-
Novartis Contract Manufacturing Services Capacity Update October 2024: Fill/Finish
10/25/2024
Let us support your high-quality medicines with integrated offerings in mammalian drug substances and drug products, including our fill and finish services for vials, syringes, cartridges, and auto-injectors.
-
Ajinomoto Bio-Pharma Capacity Update October 2024: Fill/Finish
10/25/2024
Explore our exceptional injectable manufacturing capabilities, featuring our high-speed, multi-purpose fill-finish line for vials, syringes, and cartridges at our San Diego facility.
-
Theragent Capacity Update October 2024: Cell & Gene Therapy
10/24/2024
Our Arcadia, CA facilities provide cell therapy development, testing, manufacturing, a proprietary digital trial platform, and preclinical research through our Discovery Center.
-
Viralgen Capacity Update October 2024: Cell & Gene Therapy
10/24/2024
Advance your rAAV gene therapy from concept to commercial scale, leveraging our world-leading expertise and capacity to bring life-changing treatments to patients in need.